Aistemos’s patent intelligence software, Cipher, now includes MaxVal’s international patent litigation data
Facebook seeks patent for surfacing employment opportunities on social media. Read about this and other recently published patent applications.
FDA’s Center for Devices and Radiological Health (CDRH) approved a record-breaking 106 new medical devices in 2018. Medical devices approved by the FDA include Class I, Class II and Class III devices, categorized based on the potential risks involved in their use. Read all about it in this month's newsletter.
In today's post, we look at Qualcomm, who has secured a patent for wireless charging of vehicles. Read about this and other recently published patents.
A new patent application hints at Facebook's plans to bring payment transactions into its messenger application. Read about it and other patent applications of the week in this post.
Qualcomm has been awarded a patent for displays in autonomous vehicles. Learn about this and other recently published patents in today's post.
In this post, we take you through some of the recent patent applications filed by Facebook, Intel, Google, Qualcomm, Amazon, Apple, Medtronic, Novartis, Boston Scientific, Abbott, Merck, and Roche.
In this post, we take you through some of the recent patents from Apple, Google, Qualcomm, Amazon, Intel, Facebook, Merck, Medtronic, Novartis, Pfizer, and Roche.
MaxVal’s new semiweekly column provides insights into recently issued patents and applications for some of the most innovative companies in the world.
Additional Patent Term Adjustment (PTA) may be available for some cases where an Information Disclosure Statement (IDS) was filed after a reply. Recently in Supernus Pharmaceuticals, Inc. v. Iancu, the U.S. Court of Appeals for the Federal Circuit held that the USPTO had incorrectly reduced the PTA based on applicant delay for a period of time during which there was no action that the applicant could take to conclude prosecution of the patent.